[Form 4] EXACT SCIENCES CORP Insider Trading Activity

Bloomer Aaron reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Bloomer Aaron reported acquisition or exercise transactions in this Form 4 filing.

Exact Sciences EVP and CFO Aaron Bloomer received an equity award of 28,063 restricted stock units. Each unit represents a contingent right to receive one share of common stock at no purchase price.

These restricted stock units vest in four equal annual installments beginning on February 25, 2027. After this award, Bloomer directly holds 48,768 shares of common stock and an additional 417 shares are held indirectly in a 401(k) plan, totaling 49,185 shares. He also holds, in the aggregate, 32,458 restricted stock units.

Insider Trade Summary

Grant/Award: 28,063 shares

Grant/Award 3 txns

Insider Bloomer Aaron

Role EVP, Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	28,063	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 28,063 contracts (Direct); Common Stock — 48,768 shares (Direct); Common Stock — 417 shares (Indirect, Held in 401(k) Plan)

Footnotes (3)

1. F1. In addition to the shares of Common Stock reported on this Form 4, which total 49,185 shares, Mr. Bloomer also holds, in the aggregate, an additional 32,458 restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
2. F2. Each restricted stock unit represents a contingent right to receive one share of common stock.
3. F3. These restricted stock units vest in four equal annual installments beginning on February 25, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bloomer Aaron

(Last) (First) (Middle)

C/O EXACT SCIENCES CORP

5505 ENDEAVOR LANE

(Street)

MADISON WI 53719

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EXACT SCIENCES CORP [ EXAS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								48,768(1)	D
Common Stock								417	I	Held in 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	02/25/2026		A		28,063		(3)	(3)	Common Stock	28,063	$0	28,063	D

Explanation of Responses:

1. In addition to the shares of Common Stock reported on this Form 4, which total 49,185 shares, Mr. Bloomer also holds, in the aggregate, an additional 32,458 restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.

2. Each restricted stock unit represents a contingent right to receive one share of common stock.

3. These restricted stock units vest in four equal annual installments beginning on February 25, 2027.

	/s/ Aaron Bloomer by Mark Busch, attorney-in- fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.